Skip to content
Preprint · CC-BY via OpenAlex

Rapamycin for longevity: opinion article

Mikhail V. Blagosklonny

Aging · 2019 · ▲ 217 citations

Abstract

From the dawn of civilization, humanity has dreamed of immortality. So why didn't the discovery of the anti-aging properties of mTOR(definition) inhibitors change the world forever? I will discuss several reasons, including fear of the actual and fictional side effects of rapamycin(definition), everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today. Furthermore, the alternative to the reversible (and avoidable) side effects of rapamycin/everolimus are the irreversible (and inevitable) effects of aging: cancer, stroke, infarction, blindness and premature death. I will also discuss why it is more dangerous not to use anti-aging drugs than to use them and how rapamycin-based drug combinations have already been implemented for potential life extension in humans. If you read this article from the very beginning to its end, you may realize that the time is now.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/aging.102355
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Blagosklonny, M.V. (2019). Rapamycin for longevity: opinion article. <em>Aging</em>. https://doi.org/10.18632/aging.102355
Vancouver
Blagosklonny MV. Rapamycin for longevity: opinion article. Aging. 2019. doi:10.18632/aging.102355.
BibTeX
@unpublished{mikhail2019Rapamy, title = {Rapamycin for longevity: opinion article}, author = {Mikhail V. Blagosklonny}, journal = {Aging}, year = {2019}, doi = {10.18632/aging.102355}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings